Free tool
FAERS Monitor: Cuvrior
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 215760 or its brand name (Cuvrior, Trientine Tetrahydrochloride). Reports on generic versions are filed under their own applications.
Reports
307
Serious
106
35% of reports
Hospitalization
50
Death reported
13
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use79
- product dose omission issue71
- nausea22
- treatment noncompliance21
- malaise10
- abdominal pain upper9
- fatigue9
- maternal exposure during pregnancy9
- nasopharyngitis9
- vomiting9
- abdominal pain8
- tremor8
- abdominal discomfort7
- asthenia7
- diarrhoea7
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2017 | 1 |
| 2022 | 2 |
| 2023 | 21 |
| 2024 | 86 |
| 2025 | 162 |
| 2026 | 35 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,852 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| treatment noncomplianceSignal | 21 | 26.3 | 17.4 | 487 |
| product dose omission issueSignal | 71 | 16.5 | 13.5 | 1,036 |
| maternal exposure during pregnancySignal | 9 | 6.9 | 3.6 | 40 |
| off label useSignal | 79 | 6.2 | 5.1 | 353 |
| nasopharyngitisSignal | 9 | 3.3 | 1.8 | 13 |
| tremorSignal | 8 | 3.3 | 1.7 | 11 |
| abdominal pain upperSignal | 9 | 3.0 | 1.6 | 10 |
| abdominal discomfortSignal | 7 | 2.9 | 1.4 | 7 |
| abdominal painSignal | 8 | 2.4 | 1.2 | 5 |
| nausea | 22 | 1.9 | 1.3 | 9 |
| malaise | 10 | 1.6 | 0.8 | 2 |
| vomiting | 9 | 1.3 | 0.7 | 0 |
| asthenia | 7 | 1.3 | 0.6 | 0 |
| fatigue | 9 | 0.8 | 0.4 | 0 |
| diarrhoea | 7 | 0.7 | 0.4 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.